Development and Content Validation of the Patient’s Qualitative Assessment of Treatment – Real-World (PQAT-RW): An Instrument to Evaluate Benefits and Disadvantages of Treatments in Real-World Settings
The results of this study support the content validity of the PQAT-RW. They also demonstrate that using qualitative responses to contextualize quantitative responses provides unique insight into diverse and individualized patient-perceived benefits and disadvantages, and their relative importance, in real-world settings.
Authors
- Matthew Reaney (ORCID: https://orcid.org/0000-0003-2918-722X)
- Keri J. S. Brady (ORCID: https://orcid.org/0000-0001-6417-0840)
- Amy Findley (ORCID: https://orcid.org/0000-0001-9887-6956)
- Denise Bury
- Adam Gater (ORCID: https://orcid.org/0000-0001-9582-8596)
- Aude Roborel de Climens (ORCID: https://orcid.org/0000-0002-5065-2010)
Institutions
- IQVIA (United Kingdom) (GB)
- AVEO Oncology (United States) (US)
- Adelphi Group (United Kingdom) (GB)
- Sanofi (United States) (US)
- IQVIA (France) (FR)
Publication Details
- Journal
- Patient Related Outcome Measures
- Published
- 2024-10-01
- DOI
- https://doi.org/10.2147/prom.s468623
- Citations
- 3
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 3.39
Funders
- Sanofi